https://www.nice.org.uk/guidance/ta820
Overview | Brolucizumab for treating diabetic macular oedema | Guidance | NICE
Evidence-based recommendations on brolucizumab (Beovu) for diabetic macular oedema in adults
macular oedemaoverviewbrolucizumabtreatingdiabetic
https://www.nice.org.uk/guidance/ta274?unlid=490889487201651271932
Overview | Ranibizumab for treating diabetic macular oedema | Guidance | NICE
Evidence-based recommendations on ranibizumab (Lucentis) for treating diabetic macular oedema
macular oedemaoverviewranibizumabtreatingdiabetic
https://www.nice.org.uk/guidance/ta346?unlid=60414705620161623933
Overview | Aflibercept for treating diabetic macular oedema | Guidance | NICE
Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by diabetic macular oedema in adults
macular oedemaoverviewaflibercepttreatingdiabetic
https://www.nice.org.uk/guidance/ta229/documents/macular-oedema-retinal-vein-occlusion-dexamethasone-review-decision-january-2015
Background information | Dexamethasone intravitreal implant for the treatment of macular oedema...
Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating macular oedema following retinal vein occlusion in adults
background informationintravitreal implantthe treatmentdexamethasone
https://www.nice.org.uk/guidance/ta229/resources
Tools and resources | Dexamethasone intravitreal implant for the treatment of macular oedema...
Evidence-based recommendations on dexamethasone intravitreal implant (Ozurdex) for treating macular oedema following retinal vein occlusion in adults
tools and resourcesintravitreal implant
https://www.cochrane.org/ru/evidence/CD009510_anti-vascular-endothelial-growth-factor-macular-oedema-secondary-branch-retinal-vein-occlusion
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein...
endothelial growth factor
https://www.nice.org.uk/guidance/ta1004
Overview | Faricimab for treating visual impairment caused by macular oedema after retinal vein...
Evidence-based recommendations on faricimab (Vabysmo) for treating visual impairment caused by macular oedema after retinal vein occlusion in adults
https://www.news-medical.net/news/2006/01/26/15649.aspx
Aston Academy investigates macular oedema
Jun 18, 2019 - Aston Academy of Life Sciences, the clinical research hospital of Aston University, has recently been commissioned to assess the efficacy and safety of a...
aston academyinvestigatesmacularoedema